Prophylaxis of upper limb deep vein thrombosis in cancer patients with central vein catheter

Melina Verso; Giancarlo Agnelli

doi:10.1160/TH08-03-0199

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2008; 100(01): 167-168
DOI: 10.1160/TH08-03-0199

Letters to the Editor

Schattauer GmbH

Prophylaxis of upper limb deep vein thrombosis in cancer patients with central vein catheter

Authors

Melina Verso

¹Medicina Interna e Cardiovascolare-Stroke Unit, Università di Perugia, Perugia, Italy
Giancarlo Agnelli

¹Medicina Interna e Cardiovascolare-Stroke Unit, Università di Perugia, Perugia, Italy

Abstract

Full Text

References

References
1 Bern HM, Lokich JJ, Wallach SR. et al. Very low dose of warfarin can prevent thrombosis in central venous catheters: a randomized, prospective trial. Ann Inter Med 1990; 112: 423-428.
2 Monreal M, Alastrue A, Rull M. et al. Upper extremity deep venous thrombosis in cancer patients with venous access devices. Prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 1996; 75: 251-253.
3 Verso M, Agnelli G, Bertoglio S. et al. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheters: a double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol 2005; 23: 4057-4062.
4 Karthaus M, Kretzschmar A, Kröning H. et al. A Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Ann Oncol 2006; 17: 289-296.
5 Couban S, Goodyear M, Burnell M. et al. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol 2005; 23: 4063-4069.
6 Young AM, Begum G, Billingham LJ. WARP-a multicentre, prospective, randomized controlled trial of thrombosis prophylaxis with warfarin in cancer patients with central venous catheters (CVCs). Ann ASCO Meet. 2005 Abstr 8004..
7 Geerts WH, Pineo GF, Heit JA. et al. Prevention of venous thromboembolism. Chest 2004; 126: 338S-400S.
8 Chaukiyal P, Nautiyal A, Radhakrishnan S. et al. Thromboprophylaxis in cancer patietns with central venous catheters. A systematic review and metanalysis. Thromb Haemost 2008; 99: 38-43.
9 Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 2003; 21: 3665-3675.
10 Agnelli G, Verso M. Is antithrombotic prophylaxis required in cancer patients with central venous catheters? No. J Thromb Haemost 2006; 04: 14-15.
11 Agnelli G, Verso M. Therapy insight: venous catheter-related thrombosis in cancer patients. Nat Clin Pract Oncol 2006; 03: 214-222.
12 Blom JW, Doggen CJM, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations and the risk of venous thrombosis. J Am Med Assoc 2005; 293: 715-722.
13 Lee AYY, Levine MN, Butler G. et al. Incidence, risk factors and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol 2006; 24: 1404-1408.
14 Dentali F, Gianni M, Agnelli G. et al. Association between inherited thrombophilic abnormalities and central venous catheter thrombosis in patients with cancer: a meta-analysis. J Thromb Haemost 2008; 06: 70-75.
15 Verso M, Agnelli G, Kamphuisen P. et al. Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheterin cancer patients. Intern Emerg Med. 2008 epub ahead of print